Nutra Pharma Corp (NPHC.OB) Expands Licensing Agreement to Include Environmental Testing for Nontuberculous Mycobacterium
Nutra Pharma Corp. (NPHC.OB), a biotechnology company focused on developing drugs for HIV and Multiple Sclerosis, announced that the company has expanded their licensing agreement with NanoLogix, Inc. ( NNLX.PK). Consequently, this agreement will now include the exchange of intellectual property for the testing of NonTuberculous Mycobacterium treatments. NonTuberculous Mycobacterium, also known as atypical Tuberculosis, is a bacterium that is found in water, including hot tubs and showers, some domestic and wild animals, and soil. One of the most common forms of NTM infections found in humans is Mycobacterium avium complex a leading cause of respiratory disease and a leading…